{"data":{"ticker":"SYRE","name":"Spyre Therapeutics, Inc.","cik":"0001636282","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":0,"netIncome":-40107000,"epsDiluted":0.86,"fiscalPeriod":"Q3 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2023Q4","end":"2023-12-31","revenue":0,"netIncome":-63180000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2024Q1","end":"2024-03-31","revenue":0,"netIncome":-43857000,"epsDiluted":0.72,"fiscalPeriod":"Q1 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q2","end":"2024-06-30","revenue":0,"netIncome":-38837000,"epsDiluted":0.59,"fiscalPeriod":"Q2 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q3","end":"2024-09-30","revenue":0,"netIncome":-69028000,"epsDiluted":1.06,"fiscalPeriod":"Q3 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q4","end":"2024-12-31","revenue":0,"netIncome":-56296000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2025Q1","end":"2025-03-31","revenue":null,"netIncome":-44773000,"epsDiluted":null,"fiscalPeriod":"Q1 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q2","end":"2025-06-30","revenue":null,"netIncome":-36717000,"epsDiluted":null,"fiscalPeriod":"Q2 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q3","end":"2025-09-30","revenue":null,"netIncome":-11183000,"epsDiluted":null,"fiscalPeriod":"Q3 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q4","end":"2025-12-31","revenue":null,"netIncome":-62530000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2026Q1","end":"2026-03-31","revenue":null,"netIncome":-69005000,"epsDiluted":-0.74,"fiscalPeriod":"Q1 FY 2026","fiscalYear":"FY 2026"},{"frame":"CY2026Q2","end":"2026-06-30","revenue":null,"netIncome":-36200000,"epsDiluted":null,"fiscalPeriod":"Q2 FY 2026","fiscalYear":"FY 2026"}],"annual":[{"frame":"CY2020","end":"2020-12-31","fiscalYear":"FY 2020","revenue":0,"netIncome":-80893000,"operatingCashFlow":-75775000,"capex":4280000,"buybacks":null,"dividends":null},{"frame":"CY2021","end":"2021-12-31","fiscalYear":"FY 2021","revenue":18739000,"netIncome":-65801000,"operatingCashFlow":-53716000,"capex":573000,"buybacks":null,"dividends":null},{"frame":"CY2022","end":"2022-12-31","fiscalYear":"FY 2022","revenue":2329000,"netIncome":-83815000,"operatingCashFlow":-80144000,"capex":38000,"buybacks":null,"dividends":null},{"frame":"CY2023","end":"2023-12-31","fiscalYear":"FY 2023","revenue":886000,"netIncome":-338790000,"operatingCashFlow":-99910000,"capex":0,"buybacks":null,"dividends":null},{"frame":"CY2024","end":"2024-12-31","fiscalYear":"FY 2024","revenue":0,"netIncome":-208018000,"operatingCashFlow":-157410000,"capex":0,"buybacks":null,"dividends":null},{"frame":"CY2025","end":"2025-12-31","fiscalYear":"FY 2025","revenue":0,"netIncome":-155203000,"operatingCashFlow":-169252000,"capex":null,"buybacks":null,"dividends":null}],"latest":{"end":"2026-06-30","cash":162007000,"debt":null,"equity":1101141000,"assets":1173003000,"sharesOutstanding":88173762,"sharesDate":"2026-07-28","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},"updatedAt":"2026-10-29T08:20:03.176Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/syre","meta":{"source":"SEC","sourceAttribution":"Financial statement data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}